October 31, 2019

J&J says no asbestos detected in new tests of baby powder

J&J says no asbestos detected in new tests of baby powder

No asbestos was detected in 15 new tests of the same bottle of Johnson & Johnson's Baby Powder previously found to contain asbestos by the U.S. Food and Drug Administration, the company said Tuesday.

It also said that no asbestos was found in 48 new laboratory tests of samples from Johnson & Johnson's Baby Powder recalled earlier this month, CBS News reported.

Earlier this month, Johnson & Johnson recalled 33,000 bottles of Baby Powder after the FDA found trace amounts of asbestos in a single bottle purchased online. The new tests "were conducted by two third-party laboratories as part of the 's ongoing testing and investigation," according to a Johnson & Johnson news release.

The company faces thousands of lawsuits from people claiming they developed cancer from in the talc-based powder. Johnson & Johnson has maintained there is no science to support the alleged connection between its powder and cancer, CBS News reported.

More information: CBS News Article
J&J Press Release

Copyright © 2018 HealthDay. All rights reserved.

Citation: J&J says no asbestos detected in new tests of baby powder (2019, October 31) retrieved 25 April 2024 from https://medicalxpress.com/news/2019-10-jj-asbestos-baby-powder.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

J&J recalls baby powder after trace asbestos found in bottle
2 shares

Feedback to editors
Link between depression and cardiovascular disease explained: They partly develop from same gene module

3 hours ago
Study highlights increased risk of second cancers among breast cancer survivors

8 hours ago
Opioids during pregnancy not linked to substantially increased risk of psychiatric disorders in children

9 hours ago
Research identifies pitfalls and opportunities for generative AI in patient messaging systems

9 hours ago
A closed-loop drug-delivery system could improve chemotherapy

10 hours ago
It's easier now to treat opioid addiction with medication—but use has changed little, study finds

10 hours ago
Solving the riddle of the sphingolipids in coronary artery disease

10 hours ago
New AI technology estimates brain age using low-cost EEG device

11 hours ago
Alteration of brain network condition could predict painful vaso-occlusive crisis in patients with sickle cell disease

12 hours ago
Trials reveal that internet-based conversations help sustain brain function in older adults

12 hours ago
Load comments (0)